Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.152 USD | -2.45% | -9.17% | -9.15% |
05-10 | Edesa Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
03-05 | Top Premarket Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.15% | 13.35M | |
+8.38% | 114B | |
+10.13% | 104B | |
+0.44% | 22.57B | |
-11.69% | 22.5B | |
-10.74% | 17.95B | |
-41.90% | 16.48B | |
-16.00% | 15.82B | |
+2.28% | 13.55B | |
+20.54% | 10.99B |
- Stock Market
- Equities
- EDSA Stock
- News Edesa Biotech, Inc.
- Edesa Biotech Secures Fast-Track Designation for Potential Acute Respiratory Distress Syndrome Drug Candidate